Published in Front Cell Infect Microbiol on May 01, 2017
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med (1993) 18.56
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Immunology of tuberculosis. Annu Rev Immunol (2001) 14.26
Variation in protection by BCG: implications of and for heterologous immunity. Lancet (1995) 9.66
Treatment of multidrug-resistant tuberculosis. N Engl J Med (1993) 7.44
Activation and signaling of the p38 MAP kinase pathway. Cell Res (2005) 5.48
The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics (1995) 4.72
Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med (1998) 3.64
A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis. Nat Med (2011) 3.60
Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med (2007) 3.21
The BCG story: lessons from the past and implications for the future. Rev Infect Dis (1989) 2.78
Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol (1997) 2.58
Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol (2007) 2.43
Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med (2010) 2.35
Preventing tuberculosis with bacillus Calmette-Guérin vaccine: a meta-analysis of the literature. Clin Infect Dis (2000) 1.92
Long term efficacy of DOTS regimens for tuberculosis: systematic review. BMJ (2008) 1.85
Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem (2010) 1.69
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol (2002) 1.61
Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cell Microbiol (2003) 1.57
Th2 cytokines in susceptibility to tuberculosis. Curr Mol Med (2007) 1.51
Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. J Immunol (2002) 1.49
Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest (2005) 1.48
Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner. PLoS Pathog (2011) 1.46
Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect Immun (2001) 1.42
TGF-beta and 'adaptive' Foxp3(+) regulatory T cells. J Mol Cell Biol (2009) 1.34
Interleukin-12 and tuberculosis: an old story revisited. Curr Opin Immunol (2007) 1.29
Origins and evolution of antibiotic resistance. Microbiologia (1996) 1.18
History of BCG Vaccine. Maedica (Buchar) (2013) 1.07
Mycobacterium tuberculosis directs T helper 2 cell differentiation by inducing interleukin-1β production in dendritic cells. J Biol Chem (2012) 0.95
BCG vaccination in India and tuberculosis in children: newer facets. Indian J Pediatr (1995) 0.89
Small molecule-directed immunotherapy against recurrent infection by Mycobacterium tuberculosis. J Biol Chem (2014) 0.87
Inhibition of NO(2), PGE(2), TNF-α, and iNOS EXpression by Shorea robusta L.: An Ethnomedicine Used for Anti-Inflammatory and Analgesic Activity. Evid Based Complement Alternat Med (2012) 0.86
Anti-tuberculosis lead molecules from natural products targeting Mycobacterium tuberculosis ClpC1. J Ind Microbiol Biotechnol (2015) 0.83
Evaluation of the wound healing activity of Shorea robusta, an Indian ethnomedicine, and its isolated constituent(s) in topical formulation. J Ethnopharmacol (2013) 0.82
Multidrug-resistant tuberculous meningitis. Curr Neurol Neurosci Rep (2007) 0.82
Classifying diseases and remedies in ethnomedicine and ethnopharmacology. J Ethnopharmacol (2015) 0.82
Simultaneous inhibition of T helper 2 and T regulatory cell differentiation by small molecules enhances Bacillus Calmette-Guerin vaccine efficacy against tuberculosis. J Biol Chem (2014) 0.81
A modern approach to the immunotherapy of tuberculosis. Bull Int Union Tuberc Lung Dis (1991) 0.79
Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis. J Biol Chem (2015) 0.78
Antituberculosis Activity of a Naturally Occurring Flavonoid, Isorhamnetin. J Nat Prod (2016) 0.77
Natural Compounds from Mexican Medicinal Plants as Potential Drug Leads for Anti-Tuberculosis Drugs. An Acad Bras Cienc (2017) 0.76